These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8589237)

  • 1. Estimating variance functions in developmental toxicity studies.
    Bowman D; Chen JJ; George EO
    Biometrics; 1995 Dec; 51(4):1523-8. PubMed ID: 8589237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of developmental end points observed after 2,4,5-trichlorophenoxyacetic acid exposure in mice.
    Chen JJ; Gaylor DW
    Teratology; 1992 Mar; 45(3):241-6. PubMed ID: 1631778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A full likelihood procedure for analysing exchangeable binary data.
    George EO; Bowman D
    Biometrics; 1995 Jun; 51(2):512-23. PubMed ID: 7662840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.
    Carr GJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):779-91. PubMed ID: 8241373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster sampling techniques in quantal response teratology and developmental toxicity studies.
    Bieler GS; Williams RL
    Biometrics; 1995 Jun; 51(2):764-76. PubMed ID: 7662858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using historical controls in the analysis of developmental toxicity data.
    Ryan L
    Biometrics; 1993 Dec; 49(4):1126-35. PubMed ID: 8117906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tree-structured logistic models for over-dispersed binomial data with application to modeling developmental effects.
    Ahn H; Chen JJ
    Biometrics; 1997 Jun; 53(2):435-55. PubMed ID: 9235119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice.
    Platzek T; Bochert G
    Teratog Carcinog Mutagen; 1996; 16(3):169-81. PubMed ID: 8983119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative risk assessment for developmental toxicity.
    Ryan L
    Biometrics; 1992 Mar; 48(1):163-74. PubMed ID: 1581483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process of building biologically based dose-response models for developmental defects.
    Gaylor DW; Razzaghi M
    Teratology; 1992 Dec; 46(6):573-81. PubMed ID: 1290158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of multiple binary outcome studies with intentionally missing data.
    Williams P; Ryan L
    Biometrics; 1996 Dec; 52(4):1498-514. PubMed ID: 8962465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical analysis of teratologic data: problems and advancements.
    Nelson CJ; Holson JF
    J Environ Pathol Toxicol; 1978; 2(1):187-99. PubMed ID: 722220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of litter effects on dose-response modeling in teratology.
    Kupper LL; Portier C; Hogan MD; Yamamoto E
    Biometrics; 1986 Mar; 42(1):85-98. PubMed ID: 3719065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical model for fetal death, fetal weight, and malformation in developmental toxicity studies.
    Catalano PJ; Scharfstein DO; Ryan LM; Kimmel CA; Kimmel GL
    Teratology; 1993 Apr; 47(4):281-90. PubMed ID: 8322222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative developmental toxicity study of indium in rats and mice.
    Nakajima M; Takahashi H; Sasaki M; Kobayashi Y; Ohno Y; Usami M
    Teratog Carcinog Mutagen; 2000; 20(4):219-27. PubMed ID: 10910472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation bias using the beta-binomial distribution in teratology.
    Williams DA
    Biometrics; 1988 Mar; 44(1):305-9. PubMed ID: 3358995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK
    Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.